|
|
|
Volumn 22, Issue 9, 2007, Pages 103-104
|
|
FDA notifications. FDA revises Baraclude labeling for HIV patients.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
ENTECAVIR;
GUANINE;
ANTIVIRAL RESISTANCE;
ARTICLE;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
HEPATITIS B;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
UNITED STATES;
ANTIVIRAL AGENTS;
DRUG LABELING;
DRUG RESISTANCE, VIRAL;
GUANINE;
HEPATITIS B;
HIV INFECTIONS;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 42949138415
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|